BACKGROUND: Although magnetic resonance imaging (MRI)-detected white matter disease has been correlated with cognitive decline in the elderly individuals, it is unclear whether white matter disease is primarily responsible for the cognitive deterioration or whether another process is common to both white matter disease and dementia. METHODS: We examined the relationship between Alzheimer-type brain pathology at autopsy and MRI-detected cerebral white matter disease in 50 participants from the Baltimore Longitudinal Study of Aging Autopsy Program, a prospective study of aging that includes detailed cognitive assessments. RESULTS: White matter disease was quantitated in pre- and postmortem MRI scans using the Cardiovascular Health Study (CHS) criteria in a blinded manner. We found that several measures of Alzheimer's disease (AD) pathology, including the Consortium to Establish a Registry for Alzheimer's Disease score, Braak score, and a composite AD pathology score, along with hypertension, were significantly associated with CHS white matter score using univariate and multivariate ordinal regression. In contrast, amyloid angiopathy was not independently associated with CHS score. Although a clinical diagnosis of dementia was associated with CHS score in univariate analysis, the association disappeared after accounting for AD pathology. CONCLUSION: AD pathology at autopsy is associated with MRI-detected cerebral white matter disease. This relationship may explain, in part, the association between cerebral white matter disease and cognitive decline in the elderly individuals.
BACKGROUND: Although magnetic resonance imaging (MRI)-detected white matter disease has been correlated with cognitive decline in the elderly individuals, it is unclear whether white matter disease is primarily responsible for the cognitive deterioration or whether another process is common to both white matter disease and dementia. METHODS: We examined the relationship between Alzheimer-type brain pathology at autopsy and MRI-detected cerebral white matter disease in 50 participants from the Baltimore Longitudinal Study of Aging Autopsy Program, a prospective study of aging that includes detailed cognitive assessments. RESULTS: White matter disease was quantitated in pre- and postmortem MRI scans using the Cardiovascular Health Study (CHS) criteria in a blinded manner. We found that several measures of Alzheimer's disease (AD) pathology, including the Consortium to Establish a Registry for Alzheimer's Disease score, Braak score, and a composite AD pathology score, along with hypertension, were significantly associated with CHS white matter score using univariate and multivariate ordinal regression. In contrast, amyloid angiopathy was not independently associated with CHS score. Although a clinical diagnosis of dementia was associated with CHS score in univariate analysis, the association disappeared after accounting for AD pathology. CONCLUSION: AD pathology at autopsy is associated with MRI-detected cerebral white matter disease. This relationship may explain, in part, the association between cerebral white matter disease and cognitive decline in the elderly individuals.
Authors: S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg Journal: Neurology Date: 1991-04 Impact factor: 9.910
Authors: John T O'Brien; Rebecca Wiseman; Emma J Burton; Bob Barber; Keith Wesnes; Brian Saxby; Gary A Ford Journal: Ann N Y Acad Sci Date: 2002-11 Impact factor: 5.691
Authors: S M Resnick; A F Goldszal; C Davatzikos; S Golski; M A Kraut; E J Metter; R N Bryan; A B Zonderman Journal: Cereb Cortex Date: 2000-05 Impact factor: 5.357
Authors: Niels D Prins; Ewoud J van Dijk; Tom den Heijer; Sarah E Vermeer; Peter J Koudstaal; Matthijs Oudkerk; Albert Hofman; Monique M B Breteler Journal: Arch Neurol Date: 2004-10
Authors: Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Lewis H Kuller; Oscar L Lopez; Anne Newman; Norman J Beauchamp; Greg Burke; Corinne Dulberg; Annette Fitzpatrick; Linda Fried; Mary N Haan Journal: Neuroepidemiology Date: 2003 Jan-Feb Impact factor: 3.282
Authors: Reinhold Schmidt; Stefan Ropele; Christian Enzinger; Katja Petrovic; Stephen Smith; Helena Schmidt; Paul M Matthews; Franz Fazekas Journal: Ann Neurol Date: 2005-10 Impact factor: 10.422
Authors: Michael L Alosco; Michael A Sugarman; Lilah M Besser; Yorghos Tripodis; Brett Martin; Joseph N Palmisano; Neil W Kowall; Rhoda Au; Jesse Mez; Charles DeCarli; Thor D Stein; Ann C McKee; Ronald J Killiany; Robert A Stern Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Lester Y Leung; Traci M Bartz; Kenneth Rice; James Floyd; Bruce Psaty; Jose Gutierrez; W T Longstreth; Kenneth J Mukamal Journal: Arterioscler Thromb Vasc Biol Date: 2017-06-29 Impact factor: 8.311
Authors: Konstantinos Arfanakis; Arnold M Evia; Sue E Leurgans; Luis F C Cardoso; Arman Kulkarni; Nabil Alqam; Lucas F Lopes; Diego Vieira; David A Bennett; Julie A Schneider Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472
Authors: Leonardo A Rivera-Rivera; Karly A Cody; Laura Eisenmenger; Paul Cary; Howard A Rowley; Cynthia M Carlsson; Sterling C Johnson; Kevin M Johnson Journal: J Cereb Blood Flow Metab Date: 2020-03-13 Impact factor: 6.200
Authors: Katrin Morgen; Michael Schneider; Lutz Frölich; Heike Tost; Michael M Plichta; Heike Kölsch; Fabian Rakebrandt; Otto Rienhoff; Frank Jessen; Oliver Peters; Holger Jahn; Christian Luckhaus; Michael Hüll; Hermann-Josef Gertz; Johannes Schröder; Harald Hampel; Stefan J Teipel; Johannes Pantel; Isabella Heuser; Jens Wiltfang; Eckart Rüther; Johannes Kornhuber; Wolfgang Maier; Andreas Meyer-Lindenberg Journal: Alzheimers Res Ther Date: 2015-05-15 Impact factor: 6.982